HEALTH : Swedes to Test Controversial Pill
STOCKHOLM — A Swedish hospital said today that it will become the first in the world to begin testing a controversial French abortion pill as a contraceptive.
A spokesman for Stockholm’s Karolinska Hospital said the pill, called Mifepristone or RU-486, will be tested on 30 women for six months to establish whether a single monthly dose could prevent pregnancy.
The drug, made by Rousell Uclaf Co., is available in France and China, where it is used for non-surgical abortions. An anti-abortion campaign in the United States has discouraged firms there from testing the drug.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
